Insiders · IDRA

IDRA insider transactions

Idera Pharmaceuticals Inc. (IDRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IDRA

• 1032d
  SEC Form 4: Gowen Maxine sold $26 worth of shares (51 units at $0.51)

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1032d
  SEC Form 4: Milano Vincent sold $1,750 worth of shares (3,283 units at $0.53), decreasing direct ownership by 27% to 8,987 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1055d
  SEC Form 4 filed by Pillar Invest Corp

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1055d
  SEC Form 3: New insider Pillar Invest Corp claimed ownership of 636,081 shares (Amendment)

  3/A - Aceragen, Inc. (0000861838) (Issuer)
• 1055d
  SEC Form 4 filed by Pillar Invest Corp

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1081d
  SEC Form 3: New insider Pillar Invest Corp claimed ownership of 663,046 shares

  3 - Aceragen, Inc. (0000861838) (Issuer)
• 1117d
  SEC Form 4 filed by Chopra Atul

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1117d
  SEC Form 4 filed by Chopra Atul

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1117d
  SEC Form 4 filed by Chopra Atul

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1168d
  SEC Form 3: New insider Chopra Atul claimed ownership of 1,469,482 shares

  3 - Aceragen, Inc. (0000861838) (Issuer)
• 1222d
  SEC Form 4 filed by Kirby John J.

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1222d
  SEC Form 4 filed by Salain Daniel

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1222d
  SEC Form 4 filed by Jordan Andrew R

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1222d
  SEC Form 4 filed by Kraus Carl N

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1222d
  SEC Form 4 filed by Lim Bryant David

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1222d
  SEC Form 4 filed by Taylor John Clayton

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1236d
  SEC Form 4: Jordan Andrew R converted options into 402,529 shares, increasing direct ownership by 815% to 451,890 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1236d
  SEC Form 4 filed by Wooten Ronald J

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1236d
  SEC Form 4: Salain Daniel converted options into 1,341,764 shares, increasing direct ownership by 1,051% to 1,469,482 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1236d
  SEC Form 4 filed by Kraus Carl N

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1236d
  SEC Form 4: Taylor John Clayton converted options into 1,341,764 shares, increasing direct ownership by 1,051% to 1,469,482 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1237d
  SEC Form 4 filed by Novaquest Co-Investment Fund Xv, L.P.

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1243d
  SEC Form 4: Dougherty Michael R was granted 33,523 shares, increasing direct ownership by 10% to 375,155 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1245d
  SEC Form 4: Jordan Andrew R was granted 261,718 shares and covered exercise/tax liability with 73,940 shares, increasing direct ownership by 29% to 839,142 units to cover taxes

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1245d
  SEC Form 4: Lim Bryant David was granted 399,218 shares and covered exercise/tax liability with 119,957 shares, increasing direct ownership by 918% to 309,695 units (for tax liability)

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1245d
  SEC Form 4: Kirby John J. was granted 399,218 shares and covered exercise/tax liability with 119,957 shares, increasing direct ownership by 742% to 316,893 units (for withholding tax)

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1342d
  SEC Form 4: Dougherty Michael R was granted 58,516 shares, increasing direct ownership by 21% to 341,632 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1344d
  SEC Form 4: Novaquest Co-Investment Fund Xv, L.P. acquired 5 units of Series X Preferred Stock

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1344d
  SEC Form 3 filed by new insider Novaquest Co-Investment Fund Xv, L.P.

  3 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 4: Wooten Ronald J acquired 5 units of Series X Preferred Stock

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 4: Taylor John Clayton was granted 2,171,214 shares

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 4: Salain Daniel was granted 2,171,214 shares

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 4: Jordan Andrew R was granted 651,364 shares

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 4 filed by Kraus Carl N

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 3 filed by new insider Wooten Ronald J

  3 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 3 filed by new insider Taylor John Clayton

  3 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 3 filed by new insider Kraus Carl N

  3 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 3 filed by new insider Jordan Andrew R

  3 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1347d
  SEC Form 3 filed by new insider Salain Daniel

  3 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1351d
  SEC Form 4: Pillar Invest Corp exercised 1,533,159 in-the-money shares at a strike of $0.01

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1432d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1432d
  SEC Form 4 filed by Soland Daniel B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1432d
  SEC Form 4 filed by Milano Vincent

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1432d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1433d
  SEC Form 4: Dougherty Michael R was granted 50,086 shares, increasing direct ownership by 21% to 283,116 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1442d
  SEC Form 4 filed by Goldberg Mark Alan

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1442d
  SEC Form 4 filed by Gowen Maxine

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1442d
  SEC Form 4 filed by Dougherty Michael R

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1442d
  SEC Form 4 filed by Geraghty James A

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1442d
  SEC Form 4 filed by Schafer Carol

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1442d
  SEC Form 4 filed by Csimma Cristina

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1525d
  SEC Form 4: Dougherty Michael R was granted 41,155 shares, increasing direct ownership by 21% to 233,030 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1526d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1526d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1526d
  SEC Form 4 filed by Soland Daniel B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1526d
  SEC Form 4 filed by Milano Vincent

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1594d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1594d
  SEC Form 4 filed by Soland Daniel B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1594d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1594d
  SEC Form 4 filed by Milano Vincent

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)